$RXMD Massively Underpriced and Oversold at Key Support

RXMD is in a clear bullish technical posture: at key support with multiple touches over two years and an RSI print under the "30" bull signal level. In other words, it's oversold and triggering key support in a very large time-frame bull trend.

• Telehealth regulations have been dropped to allow it to brace our healthcare system against exponential COVID-19 case growth.
RXMD is currently priced at 0.5x trailing sales, which is extremely cheap, even for a pharmacy play.
• This is especially true given that it just posted 56% top-line growth and is moving toward the likely launch of a telemedicine platform.
RXMD is moving toward a NASDAQ or NYSE uplisting.


That should read RXMD
RXMS was once billed as the perfect retirement stock. The only one you'll ever need. And that was at .05 cents. Let us pray
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out